Inecalcitol

DRUG2 trials

Sponsors

Hybrigenics Corporation

Conditions

Acute Myelogenous LeukemiaCML, Chronic Phase

Phase 2

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

Hybrigenics CorporationAcute Myelogenous Leukemia

Start: 2016-06-30End: 2019-12-31Target: 110Updated: 2017-07-02

Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study

Hybrigenics CorporationCML, Chronic Phase

Start: 2014-02-28End: 2018-04-30Target: 54Updated: 2016-10-31

Related Papers

Inecalcitol and Decitabine Synergize to Inhibit Cell Proliferation and to Induce Differentiation of Human Acute Myeloid Leukemia Cell Lines

Blood2018-11-291 citations